Table 1 Baseline characteristics of patients in ICU with CKD.
Variables | Total (n = 6380) | survivors (n = 4192) | non-survivors (n = 2188) | P |
|---|---|---|---|---|
Age (yr) | 75.5 ± 12.3 | 73.5 ± 12.6 | 79.3 ± 10.7 | < 0.001 |
Gender, n (%) | 0.006 | |||
Female | 2426 (38.0) | 1543 (36.8) | 883 (40.4) | |
Male | 3954 (62.0) | 2649 (63.2) | 1305 (59.6) | |
Race, n (%) | 0.053 | |||
White | 4344 (68.1) | 2820 (67.3) | 1524 (69.7) | |
Other | 2036 (31.9) | 1372 (32.7) | 664 (30.3) | |
Heart rate (beats/min) | 81.0 ± 14.9 | 80.3 ± 14.5 | 82.2 ± 15.7 | < 0.001 |
Average boold pressure (mmHg) | 77.5 ± 11.4 | 78.3 ± 11.5 | 75.9 ± 11.0 | < 0.001 |
Respiratory rate (bmp) | 19.2 ± 3.5 | 18.8 ± 3.3 | 19.9 ± 3.8 | < 0.001 |
Temperature (℃) | 36.7 ± 0.5 | 36.8 ± 0.4 | 36.7 ± 0.5 | < 0.001 |
Hemoglobin (g/L) | 9.6 ± 2.1 | 9.7 ± 2.1 | 9.5 ± 2.1 | < 0.001 |
White blood cell (*109/L) | 13.8 ± 11.7 | 13.4 ± 10.0 | 14.5 ± 14.4 | < 0.001 |
International normalized ratio | 1.7 ± 1.3 | 1.6 ± 1.1 | 1.9 ± 1.5 | < 0.001 |
Blood urea nitrogen (mg/dl) | 43.5 ± 26.8 | 39.5 ± 24.5 | 51.3 ± 29.3 | < 0.001 |
Creatinine (mg/dl) | 2.3 ± 1.5 | 2.2 ± 1.6 | 2.5 ± 1.4 | < 0.001 |
Albumin (g/L) | 3.2 ± 0.6 | 3.3 ± 0.6 | 3.1 ± 0.7 | < 0.001 |
Aniongap | 13.8 ± 3.4 | 13.4 ± 3.2 | 14.6 ± 3.6 | < 0.001 |
Calcium (mEq/L) | 8.3 ± 0.8 | 8.3 ± 0.8 | 8.2 ± 0.9 | 0.016 |
Sodium (mEq/L) | 137.0 ± 5.4 | 137.0 ± 5.0 | 137.0 ± 6.0 | 0.968 |
Potassium (mEq/L) | 4.8 ± 0.9 | 4.7 ± 0.9 | 4.8 ± 0.9 | < 0.001 |
Glu, Median (mg/dL) | 135.7 (115.3, 171.3) | 134.9 (116.2, 167.8) | 138.0 (113.7, 176.9) | 0.298 |
Myocardial infarct, n (%) | 0.081 | |||
No | 4652 (72.9) | 3086 (73.6) | 1566 (71.6) | |
Yes | 1728 (27.1) | 1106 (26.4) | 622 (28.4) | |
Congestive heart failure, n (%) | < 0.001 | |||
No | 3072 (48.2) | 2232 (53.2) | 840 (38.4) | |
Yes | 3308 (51.8) | 1960 (46.8) | 1348 (61.6) | |
Peripheral vascular disease, n (%) | 0.019 | |||
No | 5164 (80.9) | 3428 (81.8) | 1736 (79.3) | |
Yes | 1216 (19.1) | 764 (18.2) | 452 (20.7) | |
Cerebrovascular disease, n (%) | < 0.001 | |||
No | 5329 (83.5) | 3560 (84.9) | 1769 (80.9) | |
Yes | 1051 (16.5) | 632 (15.1) | 419 (19.1) | |
Chronic pulmonary disease, n (%) | < 0.001 | |||
No | 4451 (69.8) | 3005 (71.7) | 1446 (66.1) | |
Yes | 1929 (30.2) | 1187 (28.3) | 742 (33.9) | |
Peptic ulcer disease, n (%) | 0.243 | |||
No | 6167 (96.7) | 4060 (96.9) | 2107 (96.3) | |
Yes | 213 ( 3.3) | 132 (3.1) | 81 (3.7) | |
Diabetes mellitus, n (%) | 0.046 | |||
No | 3208 (50.3) | 2070 (49.4) | 1138 (52) | |
Yes | 3172 (49.7) | 2122 (50.6) | 1050 (48) | |
Malignant cancer, n (%) | < 0.001 | |||
No | 5568 (87.3) | 3823 (91.2) | 1745 (79.8) | |
Yes | 812 (12.7) | 369 (8.8) | 443 (20.2) | |
Severe liver disease, n (%) | < 0.001 | |||
No | 6158 (96.5) | 4097 (97.7) | 2061 (94.2) | |
Yes | 222 ( 3.5) | 95 (2.3) | 127 (5.8) | |
Sepsis3, n (%) | < 0.001 | |||
No | 3019 (47.3) | 2158 (51.5) | 861 (39.4) | |
Yes | 3361 (52.7) | 2034 (48.5) | 1327 (60.6) | |
Aki stage 7 day, n (%) | < 0.001 | |||
Stage0 | 2155 (33.8) | 1574 (37.6) | 581 (26.6) | |
Stage1 | 1093 (17.2) | 794 (19) | 299 (13.7) | |
Stage2 | 1907 (29.9) | 1254 (30) | 653 (29.9) | |
Stage3 | 1215 (19.1) | 562 (13.4) | 653 (29.9) | |
Antibiotics day 1, n (%) | < 0.001 | |||
No | 460 (10.8) | 237 (8.7) | 223 (14.5) | |
Yes | 3800 (89.2) | 2487 (91.3) | 1313 (85.5) | |
Culture positive, n (%) | < 0.001 | |||
No | 3350 (78.6) | 2216 (81.4) | 1134 (73.8) | |
Yes | 910 (21.4) | 508 (18.6) | 402 (26.2) | |
